Filing Details
- Accession Number:
- 0001486189-23-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-08 12:12:25
- Reporting Period:
- 2023-08-25
- Accepted Time:
- 2023-09-08 12:12:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1870144 | Cardio Diagnostics Holdings Inc. | CDIO | In Vitro & In Vivo Diagnostic Substances (2835) | 870925574 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1950663 | Timur Dogan | 311 W Superior St, Ste 444 Chicago IL 60654 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-08-25 | 1,770 | $0.56 | 111,864 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-08-31 | 16,481 | $0.55 | 128,345 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.